Your browser doesn't support javascript.
loading
A 3D iPSC-differentiation model identifies interleukin-3 as a regulator of early human hematopoietic specification.
Ackermann, Mania; Haake, Kathrin; Kempf, Henning; Kaschutnig, Paul; Weiss, Anna-Carina; Nguyen, Ariane H H; Abeln, Markus; Merkert, Sylvia; Kühnel, Mark Phillip; Hartmann, Dorothee; Jonigk, Danny; Thum, Thomas; Kispert, Andreas; Milsom, Michael D; Lachmann, Nico.
Afiliación
  • Ackermann M; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
  • Haake K; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
  • Kempf H; Hannover Medical School and dept. of Stem Cell Discovery, Novo Nordisk, Denmark.
  • Kaschutnig P; German Cancer Research Center (DKFZ) Heidelberg Institute for Stem Cell Technology, Germany.
  • Weiss AC; Institute of Molecular Biology, Hannover Medical School, Hannover, Germany.
  • Nguyen AHH; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
  • Abeln M; Institute of Molecular Biology, Hannover Medical School, Hannover, Germany.
  • Merkert S; REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany.
  • Kühnel MP; Institute for Pathology, Hannover Medical School, Hannover, Germany.
  • Hartmann D; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Germany.
  • Jonigk D; REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Germany.
  • Thum T; REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Germany.
  • Kispert A; Institute of Molecular Biology, Hannover Medical School, Hannover, Germany.
  • Milsom MD; German Cancer Research Center and Heidelberg Institute for Stem Cell Technology, Germany.
  • Lachmann N; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
Haematologica ; 106(5): 1354-1367, 2021 05 01.
Article en En | MEDLINE | ID: mdl-32327499
ABSTRACT
Hematopoietic development is spatiotemporally tightly regulated by defined cell-intrinsic and extrinsic modifiers. The role of cytokines has been intensively studied in adult hematopoiesis; however, their role in embryonic hematopoietic specification remains largely unexplored. Here, we used induced pluripotent stem cell (iPSC) technology and established a 3-dimensional, organoid-like differentiation system (hemanoid) maintaining the structural cellular integrity to evaluate the effect of cytokines on embryonic hematopoietic development. We show, that defined stages of early human hematopoietic development were recapitulated within the generated hemanoids. We identified KDR+/CD34high/CD144+/CD43-/CD45- hemato-endothelial progenitor cells (HEPs) forming organized, vasculature-like structures and giving rise to CD34low/CD144-/CD43+/CD45+ hematopoietic progenitor cells. We demonstrate that the endothelial to hematopoietic transition of HEPs is dependent on the presence of interleukin 3 (IL-3). Inhibition of IL-3 signalling blocked hematopoietic differentiation and arrested the cells in the HEP stage. Thus, our data suggest an important role for IL-3 in early human hematopoiesis by supporting the endothelial to hematopoietic transition of hemato-endothelial progenitor cells and highlight the potential of a hemanoid-based model to study human hematopoietic development.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interleucina-3 / Células Madre Pluripotentes / Células Madre Pluripotentes Inducidas Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interleucina-3 / Células Madre Pluripotentes / Células Madre Pluripotentes Inducidas Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Año: 2021 Tipo del documento: Article